New laser could keep melasma from coming back
NCT ID NCT06644157
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a special 1064nm laser can treat melasma and prevent it from returning. Thirty adults with moderate to severe melasma will receive laser on one side of their face every two weeks for 12 weeks, while using sunscreen and a depigmenting cream on their whole face. The other side serves as a comparison. The goal is to see if the laser reduces the severity and relapse of this common skin condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
1064nm 650 microsecond laser (Aerolase Neo Elite)
What this could lead to
If it works, this laser could reduce melasma relapses and improve treatment outcomes when combined with sunscreen and depigmenting cream.
What could go wrong
This is a small, early-stage study with only 30 people. The laser may not prevent relapses better than sunscreen alone, and results may not apply to all skin types.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELASMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Nice - Hôpital de l'Archet
Nice, Alpes-Maritimes, 06200, France